Nestle, Zydus, Abbott face India scrutiny over claims on children’s products

BENGALURU, Oct 21 (Reuters) India s food safety regulator issued notices to Nestle India, Zydus Wellness, Abbott Healthcare and others on ​Wednesday over promotional claims involving products ‌for infants and children that it said breached rules. Nestle India, Zydus Wellness and Abbott did not immediately respond to requests for comment outside regular business hours. The ‌action ​comes days after the regulator ⁠proposed banning the ⁠addition of sucrose and fructose to foods for infants up to six months old, as India steps up scrutiny of food safety ​and pushes for front-of-pack warning labels, rattling the country s more than $100 billion packaged food ⁠industry. • The Food Safety ⁠and Standards Authority of India said ​it issued notices over products including Complan, Lactogen ​Pro 1 Powder, NAN Excella Pro Stage ‌1 and infant milk substitutes. • The regulator asked Nestle India to provide evidence supporting claims about digestive and immune-system benefits for its ⁠Lactogen Pro